MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

INTENSITY THERAPEUTICS, INC. (INTS)

INTENSITY THERAPEUTICS, INC. (INTS)

|||

Cash Flow Overview

Change in Cash
-$716K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from atm offerings and ...
    • Issuance costs related to public...
    • Stock-based compensation expense
    • Others
Negative Cash Flow Breakdown
    • Proceeds from public offerings
    • Issuance costs related to public...
    • Proceeds from atm offerings and ...
Cash Flow
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Net loss
-3,007
6,121
-2,671
-5,884
Change in carrying value of right-of-use asset
7
-12
6
13
Stock-based compensation expense
387
-1,163
471
1,079
Stock issued in exchange for services
-
-
0
-
Accrued interest on marketable debt securities
-
-
0
0
Prepaid expenses, other current assets, and other assets
-47
-471
297
47
Accounts payable, accrued expenses and other liabilities
226
-411
104
394
Net cash used in operating activities
-2,340
5,006
-2,387
-4,445
Purchase of marketable debt securities
-
-
0
0
Redemption of marketable debt securities
-
-
0
0
Net cash provided by investing activities
-
-
0
0
Proceeds from public offerings
-4,652
-
0
4,652
Issuance costs related to public offerings and atm offerings-Public Offering
-933
-
0
933
Proceeds from atm offerings and common stock issuances-ATMOffering
1,664
-7,727
7,539
345
Proceeds from exercise of warrants and options
-
-
0
0
Issuance costs related to public offerings and atm offerings-ATMOffering
60
-311
301
17
Proceeds from atm offerings and common stock issuances-Common Stock Issuances
-4
-
0
24
Net cash provided by financing activities
1,624
-11,159
7,238
4,071
Net decrease in cash and cash equivalents
-716
-6,153
4,851
-374
Cash and cash equivalents at beginning of period
7,067
7,067
2,590
-
Cash and cash equivalents at end of period
9,529
10,245
7,067
-
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

something is missing$3,743K Proceeds from atmofferings and common stock...$1,664K (382.32%↑ Y/Y)Issuance costs related topublic offerings and...-$933K (-200.00%↓ Y/Y)Net cash provided byfinancing activities$1,624K (-60.11%↓ Y/Y)Canceled cashflow$4,716K Net decrease in cashand cash...-$716K (-91.44%↓ Y/Y)Canceled cashflow$1,624K Stock-based compensationexpense$387K (-64.13%↓ Y/Y)Accounts payable,accrued expenses and...$226K (-42.64%↓ Y/Y)Prepaid expenses, othercurrent assets, and...-$47K (-200.00%↓ Y/Y)Change in carryingvalue of right-of-use...$7K (-46.15%↓ Y/Y)Proceeds from publicofferings-$4,652K (-200.00%↓ Y/Y)Issuance costs related topublic offerings and...$60K (252.94%↑ Y/Y)Proceeds from atmofferings and common stock...-$4K (-116.67%↓ Y/Y)Net cash used inoperating activities-$2,340K (47.36%↑ Y/Y)Canceled cashflow$667K Net loss-$3,007K (48.90%↑ Y/Y)